IVA
Price
$3.06
Change
+$0.05 (+1.66%)
Updated
Apr 4 closing price
Capitalization
286.52M
48 days until earnings call
TVGN
Price
$1.01
Change
+$0.01 (+1.00%)
Updated
Apr 4 closing price
Capitalization
187.57M
Ad is loading...

IVA vs TVGN

Header iconIVA vs TVGN Comparison
Open Charts IVA vs TVGNBanner chart's image
Inventiva SA
Price$3.06
Change+$0.05 (+1.66%)
Volume$75.75K
Capitalization286.52M
Tevogen Bio Holdings
Price$1.01
Change+$0.01 (+1.00%)
Volume$742.75K
Capitalization187.57M
IVA vs TVGN Comparison Chart
Loading...
IVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IVA vs. TVGN commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVA is a Hold and TVGN is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (IVA: $3.02 vs. TVGN: $1.00)
Brand notoriety: IVA and TVGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IVA: 166% vs. TVGN: 66%
Market capitalization -- IVA: $286.52M vs. TVGN: $187.57M
IVA [@Biotechnology] is valued at $286.52M. TVGN’s [@Biotechnology] market capitalization is $187.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IVA’s FA Score shows that 0 FA rating(s) are green whileTVGN’s FA Score has 1 green FA rating(s).

  • IVA’s FA Score: 0 green, 5 red.
  • TVGN’s FA Score: 1 green, 4 red.
According to our system of comparison, TVGN is a better buy in the long-term than IVA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IVA’s TA Score shows that 4 TA indicator(s) are bullish while TVGN’s TA Score has 3 bullish TA indicator(s).

  • IVA’s TA Score: 4 bullish, 5 bearish.
  • TVGN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, IVA is a better buy in the short-term than TVGN.

Price Growth

IVA (@Biotechnology) experienced а -0.77% price change this week, while TVGN (@Biotechnology) price change was -16.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.73%. For the same industry, the average monthly price growth was -16.65%, and the average quarterly price growth was -18.36%.

Reported Earning Dates

IVA is expected to report earnings on May 23, 2025.

TVGN is expected to report earnings on Apr 17, 2023.

Industries' Descriptions

@Biotechnology (-10.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IVA($287M) has a higher market cap than TVGN($188M). IVA YTD gains are higher at: 41.121 vs. TVGN (-2.913).
IVATVGNIVA / TVGN
Capitalization287M188M153%
EBITDAN/A52.1M-
Gain YTD41.121-2.913-1,412%
P/E RatioN/A2.88-
RevenueN/A0-
Total CashN/A2.33M-
Total DebtN/A2.97M-
TECHNICAL ANALYSIS
Technical Analysis
IVATVGN
RSI
ODDS (%)
Bearish Trend 4 days ago
83%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
47%
Momentum
ODDS (%)
Bullish Trend 3 days ago
69%
Bearish Trend 3 days ago
49%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
38%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
59%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
69%
Bearish Trend 3 days ago
66%
Advances
ODDS (%)
Bullish Trend 12 days ago
74%
Bullish Trend 25 days ago
59%
Declines
ODDS (%)
Bearish Trend 20 days ago
83%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 3 days ago
73%
View a ticker or compare two or three
Ad is loading...
IVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HCPIX104.61N/A
N/A
ProFunds UltraSector Health Care Inv
IMCVX9.39N/A
N/A
Voya Multi-Manager Mid Cap Value I
EKBDX12.88N/A
N/A
Allspring Diversified Cap Bldr Adm
VREMX7.48N/A
N/A
Virtus SGA Emerging Markets Equity R6
LTFOX19.08N/A
N/A
Lord Abbett Affiliated F3

IVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IVA has been loosely correlated with DRUG. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if IVA jumps, then DRUG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVA
1D Price
Change %
IVA100%
-2.58%
DRUG - IVA
39%
Loosely correlated
-6.20%
TVGN - IVA
32%
Poorly correlated
-6.54%
OCGN - IVA
24%
Poorly correlated
-7.30%
IMMP - IVA
23%
Poorly correlated
-3.59%
MRNA - IVA
23%
Poorly correlated
-7.18%
More

TVGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, TVGN has been loosely correlated with TNFA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if TVGN jumps, then TNFA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TVGN
1D Price
Change %
TVGN100%
-6.54%
TNFA - TVGN
36%
Loosely correlated
+0.02%
IVA - TVGN
33%
Poorly correlated
-2.58%
DRUG - TVGN
29%
Poorly correlated
-6.20%
SCPX - TVGN
28%
Poorly correlated
-3.26%
COGT - TVGN
26%
Poorly correlated
-6.82%
More